• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.175-176
• /
• 2002

Airway inflammation is a characteristic of many lung disorders including asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis. All these diseases involve the recruitment of immune and inflammatory cells to the lungs leading to systemic and local chronic inflammation and oxidative stress. (omitted)

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제30권2호
• /
• pp.150-156
• /
• 2004

The etiology of the obstructive sleep apnea includes the various factors such as anatomical abnormality in upper airway, craniofacial structure, obesity and personal habit. To establish reasonable treatment plan, multi-department approach is should be emphasized because the treatment modality is depend on the result of analysis for degree & site of obstruction and various behavioral factors. In Sleep Clinic in Keimyung University Medical Center, the standard of care for sleep apnea patient was established according to the Standard of practice committee of Americal Sleep Disorders Association. After one year experience of comprehensive approach for sleep apnea we could achieve following recommendation for the treatment. 1) The multi-department examination and diagnosis could prevent unnessesary treatment because the treatment plan could be established under comprehensive discussion. 2) Determination of the site of obstruction is important for treatment planning. However, no single determinant could be found. We expect multi-department approach can reduce the mistake in detection of obstruction. 3) Further evaluation of treatmet outcome should be succeeded to establish Korean standard of care for sleep apnea treatment.

• BMB Reports
• /
• 제50권2호
• /
• pp.79-84
• /
• 2017

Emphysema, a pathologic component of the chronic obstructive pulmonary disease, causes irreversible destruction of lung. Many researchers have reported that mesenchymal stem cells can regenerate lung tissue after emphysema. We evaluated if spheroid human adipose-derived mesenchymal stem cells (ASCs) showed greater regenerative effects than dissociated ASCs in mice with elastase-induced emphysema. ASCs were administered via an intrapleural route. Mice injected with spheroid ASCs showed improved regeneration of lung tissues, increased expression of growth factors such as fibroblast growth factor-2 (FGF2) and hepatocyte growth factor (HGF), and a reduction in proteases with an induction of protease inhibitors when compared with mice injected with dissociated ASCs. Our findings indicate that spheroid ASCs show better regeneration of lung tissues than dissociated ACSs in mice with elastase-induced emphysema.

• 한국콘텐츠학회:학술대회논문집
• /
• 한국콘텐츠학회 2015년도 춘계 종합학술대회 논문집
• /
• pp.145-146
• /
• 2015

폐쇄성수면무호흡증(Obstructive sleep apnea syndrome : OSAS)은 신경근육계, 호흡계, 심혈관계의 복합적인 질환으로서 사회적, 생리학적으로 심각한 문제를 발생시킬 수 있는 질병이다. 수술적치료를 결정하기에 앞서 환자의 증상 및 징후, 신체 상태와 습관 등을 정밀검사하고, 기도폐쇄가 일상생활 및 정신건강에 미치는 영향을 고려하여 수술여부를 결정하여야 한다. 폐쇄성수면무호흡증후군의 진단에 유용한 검사인 수면다원검사와 Videofluoroscopy의 검사결과를 바탕으로 수술소견을 비교분석하고자 하였다.

• 한방안이비인후피부과학회지
• /
• 제12권1호
• /
• pp.295-312
• /
• 1999

A literature study on the nasal stuffiness, the results are as follows. 1. The pathogenic factors nasal stuffiness are wind-cold, cold, fire-heat, heart & lung disease, deficiency of lung-energy and spleen & stomach disease caused by internal damage. 2. The method on the external treatment of nasal stuffiness are obstructive method, blowing method and pouring method, obstructive method used many. 3. The method on the internal treatment of nasal stuffiness are diaphoretic therapy, clearing away heat & toxic materials and warming the lung & invigorating the spleen. 4. You-taek-tong-gue-tang is used in nasal stuffness. 5. Herba Asari, Radix Angelicae Dahuricae, Flos Magnaliae, Fructus Xanthii, Rhizama Acori Graminei, Herba Menthae, Zanthoxyli Fructus and Spina Gleditsiae are used in nasal stuffness.

• Tuberculosis and Respiratory Diseases
• /
• 제82권1호
• /
• pp.35-41
• /
• 2019

Background: Pulmonary tuberculosis can result in anatomical sequelae, and cause airflow limitation. However, there are no treatment guidelines for patients with a tuberculosis-destroyed lung. Recently, indacaterol effectiveness in chronic obstructive pulmonary disease (COPD) patients with Tuberculosis history (INFINITY) study revealed indacaterol provided bronchodilation and symptom improvement in COPD patients with a tuberculosis-destroyed lung. Methods: We conducted a post-hoc subgroup analysis of the randomized controlled trial, the INFINITY study, to determine factors associated with indacaterol response in a tuberculosis-destroyed lung with airflow limitation. Data from 68 patients treated with inhaled indacaterol, were extracted and analyzed. Factors associated with the response of forced expiratory volume in one second ($FEV_1$) to indacaterol treatment, were determined using linear regression analysis. Results: Of 62 patients included, 68% were male, and 52% had history of cigarette smoking. Patients revealed mean $FEV_1$ of 50.5% of predicted value with mean improvement of 81.3 mL in $FEV_1$ after indacaterol treatment for 8 weeks. Linear regression analysis revealed factors associated with response of $FEV_1$ to indacaterol included a short duration of smoking history, and high short-acting bronchodilator response. When patients with history of smoking were excluded, factors associated with response of $FEV_1$ to indacaterol included high short-acting bronchodilator response, and poor health-related quality of life score as measured by St. George's Respiratory Questionnaire for COPD. Conclusion: In a tuberculosis-destroyed lung with airflow limitation, short-acting bronchodilator response and smoking history can play a critical role in predicting outcomes of indacaterol treatment.

• Tuberculosis and Respiratory Diseases
• /
• 제83권3호
• /
• pp.234-241
• /
• 2020

Background: The fractional exhaled nitric oxide (FENO) test is useful in asthma patients. However, a few studies on its usefulness in chronic obstructive pulmonary disease (COPD) patients have been reported. We analyzed the FENO level distribution and clinical characteristics according to the FENO level in COPD patients. Methods: From December 2014 to June 2019, COPD patients who underwent pulmonary function and FENO tests at Chonnam National University Hospital were retrospectively evaluated for FENO, comorbidities, asthma history, blood eosinophil, and pulmonary function test. The high FENO group was defined as those with FENO level>25 parts per billion (ppb). Results: A total of 849 COPD patients (mean age, 70.3±9.4 years) were included. The mean forced expiratory volume at 1 second was 66.5±21.7% and the mean FENO level was 24.3±20.5 ppb. Patients with FENO ≤25 ppb were 572 (67.4%) and those with FENO >25 ppb were 277 (32.6%). Blood eosinophil percentage was significantly higher (4.2±4.8 vs. 2.7±2.5, p<0.001) in patients with the high FENO group than the low FENO group. The high FENO group revealed a significantly higher frequency of patients with blood eosinophil percentage >3% (46.9% vs. 34.8%, p=0.001) and asthma history (25.6% vs. 8.6%, p<0.001) than the lower FENO group. Asthma history, blood eosinophil percentage >3%, and positive bronchodilator response (BDR) were independent risk factors for the high FENO level (adjusted odds ratio [aOR], 3.85; p<0.001; aOR, 1.46; p=0.017; and aOR, 1.57, p=0.034, respectively) in the multivariable analysis. Conclusion: The FENO level distribution varied in COPD patients and the mean FENO value was slightly elevated. Asthma history, eosinophil percent, and positive BDR were independent risk factors for the high FENO level.

• Tuberculosis and Respiratory Diseases
• /
• 제72권1호
• /
• pp.8-14
• /
• 2012

Background: Although airway obstruction in chronic obstructive pulmonary disease (COPD) is due to pathologic processes in both the airways and the lung parenchyma, the contribution of these processes, as well as other factors, have not yet been evaluated quantitatively. We therefore quantitatively evaluated the factors contributing to airflow limitation in patients with COPD. Methods: The 213 COPD patients were aged >45 years, had smoked >10 pack-years of cigarettes, and had a post-bronchodilator forced expiratory volume in one second ($FEV_1$)/forced vital capacity (FVC) <0.7. All patients were evaluated by medical interviews, physical examination, spirometry, bronchodilator reversibility tests, lung volume, and 6-minute walk tests. In addition, volumetric computed tomography (CT) was performed to evaluate airway wall thickness, emphysema severity, and mean lung density ratio at full expiration and inspiration. Multiple linear regression analysis was performed to identify the variables independently associated with $FEV_1$ - the index of the severity of airflow limitation. Results: Multiple linear regression analysis showed that CT measurements of mean lung density ratio (standardized coefficient ${\beta}$=-0.46; p<0.001), emphysema severity (volume fraction of the lung less than -950 HU at full inspiration; ${\beta}$=-0.24; p<0.001), and airway wall thickness (mean wall area %; ${\beta}$=-0.19, p=0.001), as well as current smoking status (${\beta}$=-0.14; p=0.009) were independent contributors to $FEV_1$. Conclusion: Mean lung density ratio, emphysema severity, and airway wall thickness evaluated by volumetric CT and smoking status could independently contribute to the severity of airflow limitation in patients with COPD.

• 보건행정학회지
• /
• 제34권2호
• /
• pp.141-155
• /
• 2024

연구배경: 최근 국내 중고령층 수면무호흡증 환자 수는 증가되는 추세이며, 그 중 가장 임상적으로 흔히 나타나는 폐쇄성 수면무호흡증은 전반적인 건강 및 웰빙과 연관된다. 이에 본 연구는 한국 중고령층의 폐쇄성 수면무호흡증 위험과 주관적 건강 및 건강 관련 삶의 질 간의 연관성을 파악하고자 하였다. 방법: 2019-2020년 국민건강영양조사(Korea National Health and Nutrition Examination Survey VIII) 전체 응답자 22,559명 중 40세 이상 성인을 추출하여, 결측치가 없는 총 6,659명의 중고령층을 대상으로 데이터를 2차 분석하였다. 그리고 로지스틱 회귀분석과 다중회귀분석을 통해 폐쇄성 수면무호흡 위험 여부와 주관적 건강 및 건강 관련 삶의 질 간의 연관성을 조사하였다. 결과: 폐쇄성 수면무호흡 비위험군에 비해 위험군인 경우 주관적 건강이 저하될 오즈비는 1.84배(p<0.001) 통계적으로 유의하게 높았고, 건강 관련 삶의 질은 0.02점(β, -0.02; p<0.001) 통계적으로 유의하게 낮은 것으로 나타났다. 특정 변수에 대해 하위그룹 분석을 실시한 결과, 성별, 수면시간, 우울증 여부, 가구소득, 가구원 수에 따라 폐쇄성 수면무호흡 위험과 주관적 건강 및 건강 관련 삶의 질 간의 연관성이 통계적으로 유의하게 나타났다. 폐쇄성 수면무호흡 위험군을 기준으로 하였을 때, 남성에 비해 여성에서 주관적 건강이 낮을 연관성이 더 높았고 건강 관련 삶의 질 점수가 낮았다. 수면시간이 8시간 이상이거나 6시간 이하인 경우 6-8시간인 경우보다 주관적 건강이 낮을 연관성이 더 높았고 건강 관련 삶의 질 점수가 낮았다. 우울증이 있는 경우 없는 경우보다 주관적 건강이 낮을 연관성이 높았다. 가구소득 수준이 낮을수록, 가구원 수가 감소할수록 주관적 건강이 낮을 연관성이 높아지고 건강 관련 삶의 질 점수가 낮아졌다. 결론: 폐쇄성 수면무호흡증 위험이 단순히 수면장애로만 직결되는 것이 아니라 개인의 주관적 건강과 건강 관련 삶의 질과도 연관성이 있다는 점을 인식할 수 있도록 사회적인 지원 및 교육이 제공되어야 한다. 특히 여성, 낮은 가구소득, 1인 가구원, 우울증이 있는 취약계층을 대상으로 폐쇄성 수면무호흡증 예방 및 관리프로그램을 통해 주관적 건강과 건강 관련 삶의 질을 향상시킬 수 있도록 해야 할 것이다.

• Tuberculosis and Respiratory Diseases
• /
• 제40권6호
• /
• pp.646-652
• /
• 1993

연구배경 : 폐암과 같이 만성폐쇄성 폐질환도 고령자 및 흡연자에 많으므로 폐암환자에서 동반율이 높을 것으로 예상되며, 더우기 만성폐쇄성 폐질환이 있는 경우 폐암 발생의 위험도가 증가된다는 보고가 있으며 기존의 폐질환 및 만성적 객담 배출환자에서 폐암 발생의 위험도가 증가된다는 보고도 있다. 따라서 폐암환자에 있어 폐기능을 고찰해 보는 것이 의미있을 것으로 사료되나 국내에서의 보고가 거의 없어 폐환기능 상태에 따른 폐암의 위험인자, 종양의 병기 및 위치를 관찰하여 보고하고자 한다. 방법 : 조직학적으로 원발성 폐암으로 확진되었고 동시에 폐기능 검사가 시행된 총 72예에서 폐기능 성적을 관찰하고 폐환기능 상태에 따른 세포형태, 해부학적 병기, 종양의 위치 및 폐암의 위험인자 등을 분석하여 다음과 같은 결과를 얻었다. 결과 : 1) 정상폐기능은 6예(8.3%), 제한성 환기장애는 16예(22.2%), 중등도의 기도 폐색은 46예(63.9%), 심한 기도폐색은 4예(5.6%)였다. 2) 편평상피암, 중심성 폐종양 및 진행기의 폐종양, 기왕의 폐 질환 및 만성적 객담 배출이 있는 경우 폐기능이 저하되어 있었으나, 흡연유무 및 흡연량과는 유의있는 차이는 없었다. 3) $FEV_1$/FVC비가 75% 이하인 폐환기능 장애 환자에서 편평상피암의 빈도가 높았고 정상 폐환기능을 보인 환자들에서 소세포암의 빈도가 높았다. 결론 : 이상으로 폐암환자의 대부분에서 폐기능이 저하되어 있고, 이것은 종양의 위치 및 세포형태, 해부학적 병기, 기왕의 폐질환 및 만성적 객담 배출과 관련되었으며 폐환기능 장애를 보이는 흡연자에 있어 편평상피암의 빈도가 높음을 알 수 있었다.